Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet.

Please join the discussion by adding your comments on any of these stories, and please do let us know if you think we’ve missed something important, or if there is a source you think should be monitored.

You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://thinkipstrategy.com/subscribe/

US: Senate Judiciary Committee passes amended Preserve Access to Affordable Generics Act (S.396) banning pay-for-delay settlements (Patent Baristas)

Vigamox (Moxifloxacin) – US: District Court S D New York finds Teva infringed Alcon’s patent covering Vigamox (Patent Docs) (IP Factor)

Alphagan (Brimonidine) – US: District Court Delaware rules that proposed products by Apotex and Exela infringe Allergan’s asserted patent claims (Patent Docs) (SmartBrief) (GenericsWeb)

Disagreements remain in WHO talks on virus-sharing after Chan proposal (IP Watch)

Billable hour is dying: Pfizer sets another nail into the coffin (BLOG@IP::JUR)

Advocates warn against ‘monsantosizing’ of global food sources (IP Watch)

Brazil, India to take EU to court in generics row(GenericsWeb)

EU: Synaptech for ECJ reference: to join with Synthon v Merz? (The SPC Blog)

EU: European Federation of Pharmaceutical Industries and Associations unveils anti-counterfeit authentication system (IP Watch)

US: Time Magazine on data exclusivity debate (Patent Docs)

US: BIO’s IPCC Conference: Behind the scenes look at patent cases – Mayo v Prometheus; Bilski v Doll; Laboratory Court of Am. Holdings v Metabolite Labs (Patent Baristas)

US: BIO’s IPCC Conference: Patent re-examination in the life sciences (Patent Baristas)

US: Senate Judiciary Committee passes amended Preserve Access to Affordable Generics Act (S.396) banning pay-for-delay settlements (Patent Baristas)

US: TTOs wary of new recommendations from Task Force on IP and Genetic Testing that could weaken patent protection for genetic research (Technology Transfer Tactics)

US: Empirical research fails to support gene patenting ban (Patent Docs)

US: Banyu Pharmaceutical files suit seeking review and correction of patent term adjustment calculation for patent covering ‘fused ring 4-oxypyrimidine derivative’ (Patent Docs)

US: Rockefeller University files suit seeking review and correction of patent term adjustment for patent covering ‘methods of detecting, measuring and evaluating modulators of body weight in biological samples and diagnostic, monitoring and therapeutic uses thereof’ (Patent Docs)

US: Centre National De La Recherche Scientifique files suit seeking review and correction of patent term adjustment calculation in respect of patent covering ‘method for producing oligopolysaccharides’ (Patent Docs)

US: Gen-Probe asserts 8 patents against Becton Dickinson over its manufacture and sale of its ‘Viper’, ‘Viper with XTR Technology’ and ‘ProbeTec’ products (Patent Docs)

Alphagan (Brimonidine) – US: District Court Delaware rules that proposed products by Apotex and Exela infringe Allergan’s asserted patent claims (Patent Docs) (SmartBrief) (GenericsWeb)

Angiomax (Bivalirudin) – US: The Medicines Company continues lobbying push for Angiomax patent term extension legislative fix; latest iteration of the “Dog ate my homework act” maintains $65 million late fee (FDA Law Blog)

Caduet (Atorvastatin) – US: Sandoz files suit seeking declaratory judgment of invalidity and non-infringement of Pfizer’s patents based on Sandoz’ filing of an ANDA to manufacture generic Caduet (Patent Docs)

Circumvent, Porcilis, CircoFlex (Porcine circovirus vaccines) – US: Wyeth files patent infringement suit against Intervet, Boehringer Ingelheim Vetmedica based on their manufacture and sale of Circumvent, Porcilis and CircoFlex (Patent Docs)

Copaxone (Glatiramer) – US: Teva files patent infringement suit against Mylan and Natco following Para IV challenge (Patent Docs)

Famvir (Famciclovir) – US: Teva loses bid to have Novartis’ patent infringement suit dismissed for lack of standing (Patent Docs)

Lexapro (Escitalopram) – US: Infosint awarded $15M as reasonable royalties in patent dispute with Lundbeck and Forest over patent covering Lexapro (Patent Docs)

Lipitor (Atorvastatin) – Philippines: Pfizer files patent infringement suit against United Laboratories over generic Lipitor (GenericsWeb)

Luvox (Fluvoxamine) – US: Elan files patent infringement suit against Anchen following Para IV challenge (Patent Docs)

Namenda (Memantine) – US: Court signs off on stipulation and order resolving patent dispute between Sun India and Forest (Patent Docs) (GenericsWeb)

OxyContin (Oxycodone) – US: Purdue files patent infringement suit against Ranbaxy in response to its Para IV challenge (Patent Docs)

Taxotere (Docetaxel) – Canada: Non-jury trial begins for case in which Sanofi-Aventis unit accuses Hospira and Apotex of infringing Taxotere patents (GenericsWeb)

Toltrazuril (Traizine-based anti-coccidial) – US: Bayer Healthcare files patent infringement suit against Wedgewood Village Pharmacy over its manufacture and sale of its Toltrazuril product (Patent Docs)

Vigamox (Moxifloxacin) – US: District Court S D New York finds Teva infringed Alcon’s patent covering Vigamox (Patent Docs) (IP Factor)

Vyvanse (Lisdexamfetamine) – US: FDA determines Vyvanse was properly granted five-year market exclusivity (GenericsWeb)

Xeloda (Capecitabine) – US: Hoffmann-La Roche files patent infringement suit against Teva following Para IV challenge (Patent Docs)

Yasmin (Drospirenone, Ethinyl estradiol) –US: Bayer loses bid to have CAFC overturn ruling patent invalidity in battle with Teva (GenericsWeb)